Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials
- PMID: 32436730
- PMCID: PMC7299098
- DOI: 10.1161/CIRCEP.120.008688
Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials
Keywords: COVID-19; chloroquine; hydroxychloroquine; pandemic; trophozoites.
Figures
Similar articles
-
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27. Indian Heart J. 2020. PMID: 32534688 Free PMC article. No abstract available.
-
Regulators split on antimalarials for COVID-19.Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5. Lancet. 2020. PMID: 32278373 Free PMC article. No abstract available.
-
Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?J Am Heart Assoc. 2020 Jun 16;9(12):e016887. doi: 10.1161/JAHA.120.016887. Epub 2020 May 28. J Am Heart Assoc. 2020. PMID: 32463308 Free PMC article. Review. No abstract available.
-
COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.Am J Crit Care. 2020 Nov 1;29(6):489-492. doi: 10.4037/ajcc2020694. Am J Crit Care. 2020. PMID: 32839815 Review. No abstract available.
-
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).Am J Trop Med Hyg. 2020 May;102(5):932-933. doi: 10.4269/ajtmh.20-0230. Am J Trop Med Hyg. 2020. PMID: 32247318 Free PMC article. No abstract available.
Cited by
-
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials.Clin Transl Sci. 2023 Mar;16(3):524-535. doi: 10.1111/cts.13468. Epub 2023 Jan 4. Clin Transl Sci. 2023. PMID: 36601684 Free PMC article.
-
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.Curr Heart Fail Rep. 2022 Dec;19(6):458-466. doi: 10.1007/s11897-022-00581-y. Epub 2022 Sep 27. Curr Heart Fail Rep. 2022. PMID: 36167917 Free PMC article. Review.
-
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?Antioxid Redox Signal. 2023 Mar;38(7-9):599-618. doi: 10.1089/ars.2022.0126. Epub 2022 Dec 28. Antioxid Redox Signal. 2023. PMID: 36053670 Free PMC article. Review.
-
Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study.BMJ Open. 2022 Feb 9;12(2):e051579. doi: 10.1136/bmjopen-2021-051579. BMJ Open. 2022. PMID: 35140148 Free PMC article.
-
Cardiac involvement in the long-term implications of COVID-19.Nat Rev Cardiol. 2022 May;19(5):332-341. doi: 10.1038/s41569-021-00631-3. Epub 2021 Oct 22. Nat Rev Cardiol. 2022. PMID: 34686843 Free PMC article. Review.
References
-
- Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, et al. In vitroantiviralactivity and projection of optimizeddosingdesign of hydroxychloroquine for the treatment of severeacuterespiratorysyndromecoronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:ciaa237. doi: 10.1093/cid/ciaa237. - PMC - PubMed